X
Thank you for your feedback! ASTRO is continually looking to improve your experience on our website. Please let us know what we are doing well and where we can improve.

Suggestion:

Skip to content
Affiliates:
Other Sites:  RO Institute  RT Answers
Targeting Cancer Care
Clinical Practice

RO-ILS: Radiation Oncology Incident Learning System™

RO-ILSlogo2(1)

The mission of RO-ILS™ is to facilitate safer and higher quality care in radiation oncology by providing a mechanism for shared learning in a secure and non-punitive environment.

View the RO-ILS Congressional Briefing
Slides from the RO-ILS Congressional Briefing 

ASTRO membership is not required for RO-ILS participation; however, you do need a Web User ID to log in and download the Participation Guide. If you do not have a Web User ID, you can create one here.

Access the Participation Guide 

In June 2011, ASTRO's Board of Directors approved a proposal to establish a national radiation oncology-specific incident learning system. A standardized system provides an opportunity for shared learning across all radiation oncology institutions and may be an added value to institutions that track incidents independently. This incident learning system represents a key commitment of Target Safely, ASTRO’s patient protection plan, designed to improve the safety and quality of radiation oncology.

ASTRO partnered with the American Association of Physicists in Medicine (AAPM) to develop RO-ILS: Radiation Oncology Incident Learning System, the only medical specialty society-sponsored incident learning system for radiation oncology.

RO-ILS facilitates patient safety reporting and serves as a national incident learning system to build awareness about radiation oncology practice risks. ASTRO serves as the gateway for providers interested in RO-ILS participation. ASTRO contracted with Clarity Group Inc. and Clarity PSO, a division of Clarity Group Inc., to develop and administer RO-ILS. Clarity PSO is a federally qualified patient safety organization (PSO).

Access the Participation Guide.

Clarity Group Inc. and Clarity PSO built the RO-ILS portal using the architecture and platform of its Healthcare SafetyZone Portal, a flexible, Web-based system used by a wide range of health care providers to manage the collection and analysis of safety events across their unique delivery networks. Radiation oncology providers who contract with Clarity PSO are granted access to this secure portal to submit information on radiation oncology incidents and near-misses.

The Consensus recommendations for incident learning database structures in radiation oncology(Ford EC, Fong de Los Santos L, Pawlicki T, Sutlief S, Dunscombe P. Med Phys. 2012;39:7272-90), developed by the AAPM Work Group on Prevention of Errors in Radiation Oncology, guided the framework for developing the data elements within RO-ILS.

RO-ILS is largely consistent with other systems, such as the International Atomic Energy Agency's SAFRON (Safety in Radiation Oncology) and the Conference for Radiation Control Program Directors (CRCPD) report form structure. Modifications were made to fit the needs of PSO requirements set forth by the Agency for Healthcare Research and Quality (AHRQ).

The only patient information providers report into RO-ILS are patient's age (as a range) and gender, which are AHRQ requirements. A local identifier, although not required, may also be submitted with each report to aid with the institution's follow-up analysis. Note that original sources of information that contribute data elements, such as medical records, are not protected under the PSQIA.

Clarity Group Inc. and Clarity PSO will provide more information on the data elements, as well as the privacy, security, confidentiality and privilege aspects of the PSQIA, during training after the institution signs the contract; however, if you have specific questions on any of these topics, please contact Clarity PSO at radoncsupport@claritygrp.com.

Radiation Oncology Healthcare Advisory Council (RO-HAC)  

RO-ILS participants receive institution-specific summary reports for their institution, including aggregate data on events entered throughout the country, devloped by Clarity PSO and RO-HAC. 

RO-HAC is a group of radiation oncology professionals who provide subject-matter expertise, including helping Clarity PSO analyze, interpret and report on data submitted into RO-ILS. RO-HAC members include radiation oncologists, physicists, dosimetrists and other patient safety experts. Members of RO-HAC are compensated for their time and must sign a contract with Clarity PSO before accessing any data.

The leadership of ASTRO's Clinical Affairs and Quality Council and AAPM's Working Group on Radiation Oncology Incident Learning System (WROILS) determines and appoints members to RO-HAC, which operates as part of Clarity PSO's patient safety evaluation system and is not subject to either ASTRO or AAPM's review or oversight.

ASTRO and AAPM will issue a "call for volunteers" when new members are needed. Interested providers will need to submit and application and complete ASTRO's Conflict of Interest Disclosure Form.

Access the Participation Guide.

The Patient Safety and Quality Improvement Act of 2005 (PSQIA) authorizes the creation of PSOs to address the needs identified in the 1999 Institute of Medicine (IOM) report "To Err is Human: Building a Safer Health System." Findings within the IOM's report highlighted a serious need to capture information that would help improve quality and reduce harm to patients. The PSQIA allows licensed health care providers to report, investigate and conduct analysis of patient safety events within a confidential and privileged environment.

The Agency for Healthcare Research and Quality (AHRQ), a division in the U.S. Department of Health and Human Services, oversees the activities and compliance of federally qualified PSOs. Qualified PSOs, such as Clarity PSO, are listed on the AHRQ website. As outlined in the PSQIA, PSOs:

  • Share the goal of improving the quality and safety of health care delivery.
  • Collect and analyze data to identify and reduce the risks and hazards associated with patient care.
  • Create a secure, non-punitive environment through confidentiality and privilege protections.

Access the Participation Guide.

RO-ILS is structured to allow any provider who is part of the radiation oncology treatment team, including radiation oncologists, medical physicists, dosimetrists, nurses, technologists and practice administrators, to submit data.

ASTRO membership is not required for RO-ILS participation; however, you do need a Web User ID to log in and download the Participation Guide. If you do not have a Web User ID, you can create one here. 

Steps to Participation  

  1. Access the Participation Guide.
  2. Complete the Participation Form found at the end of the Participation Guide and send to Clarity PSO. This form collects institution-specific information and also initiates the contracting process.
  3. Review, sign and return the contract to Clarity PSO. Although there is no financial obligation to participate, institutions must sign a contract with Clarity PSO to participate in RO-ILS. ASTRO encourages providers interested in participating in RO-ILS to confer with leaders at your organization who can sign contracts.
  4. Providers can begin entering date after receiving the login information and training from Clarity PSO.
  5. Data are aggregated and analyzed by both Clarity PSO and the Radiation Oncology Healthcare Advisory Counsil (RO-HAC).
  6. Participants receive quarterly, institution-specific summary reports, including aggregate data on events submitted throughout the country.

Access the Participation Guide.

RO-ILS ensures gathered information is synthesized to provide excellent education for practitioners. Radiation oncology institutions must sign a PSO Provider Services Agreement with Clarity PSO to participate in RO-ILS.

With RO-ILS, participants can:

  • Track and analyze internal incidents while contributing to a national database.
  • Receive institution-specific summary reports, including aggregate data on events entered throughout the country.
  • Receive newsletters and other publications designed to educate the radiation oncology community on how to prevent errors.

RO-ILS is also qualified for physicians and physicists by the American Board of Radiology (ABR) in meeting the criteria for practice quality improvement (PQI), toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program. Access the RO-ILS PQI template. 

Access the Participation Guide.

Quarterly Reports  

Clarity PSO, with the help of the RO-HAC, analyze, interpret and report on data submitted into RO-ILS. Facilities receive quarterly reports containing both aggregate and provider level data, if statistically possible. These reports provide insight on patient safety in the form of a summary report card, and detailed commentary. Below, please find the recent aggregate reports.

Year in Review  

ASTRO and AAPM launched RO-ILS, a national patient safety initiative on June 19, 2014. In its first year, RO-ILS is benefiting radiation oncology by collecting vital patient safety information that will grow as participation expands. Read more about RO-ILS first year accomplishments in the Year in Review: 2015 Report 

 

ASTRO encourages providers interested in participating in RO-ILS to confer with qualified legal counsel. While these FAQ’s provide information to help familiarize you with the RO-ILS program offered by Clarity PSO, they are not intended to be legal advice. 

AUTHORITY 

What is the Patient Safety and Quality Improvement Act of 2005 (PSQIA)?
Who oversees the activities of federally listed patient safety organizations (PSOs)?
As a provider, how do I participate in RO-ILS?
Do I still have to report to federal and state agencies, if I am reporting to Clarity PSO? 

RO-ILS STAKEHOLDERS 

Who sponsors RO-ILS?
Who served on the steering committee that developed RO-ILS?
What is the Radiation Oncology Healthcare Advisory Council (RO-HAC)? How does it work?
How can I apply to become a member of RO-HAC? 

CONTRACTING 

Who can participate in the RO-ILS program?
How do I sign up?
What is the Participation Guide?
If my institution already reports to another PSO, can we still participate in RO-ILS?
Are there different requirements for contracting with Clarity PSO depending on practice setting?
Who signs the contract with Clarity PSO?
How much does it cost to participate?
Who do I contact for additional guidance during the contracting process? 

DATA COLLECTION 

How were the data elements developed?
Can we map our current incident learning system to RO-ILS?
Who is able to enter data and perform analysis?
Do I have to disclose protected health information (PHI), as defined in the Health Insurance Portability and Accountability Act (HIPAA), when entering data into the RO-ILS portal?
How do I know when to submit a report to the PSO?
How will I know the PSO received my information after I submit a report?
If I submit an event to the PSO and then add additional information, do I have to resubmit the event?
Can I query the database? 

DATA SECURITY 

How is RO-ILS set up?
How do you ensure there is no unauthorized access, use or disclosure to data with RO-ILS?
How do Clarity Group and Clarity PSO remain compliant with the Health Insurance Portability and Accountability Act (HIPAA)?
What is the best browser to use when submitting data to RO-ILS?
Can users view the RO-ILS portal over mobile or tablet devices?
Who can access the data once I submit it to RO-ILS?
Will my information be known to and shared with anyone outside of RO-ILS?"
What if I begin reporting data to RO-ILS and then choose to stop? Are the data returned to me?
What additional measures does Clarity take to ensure data security? 

RO-ILS BENEFITS 

Why should I participate in the RO-ILS?
Can participation in the RO-ILS be used for Maintenance of Certification?
What types of reports and educational material will we receive?
Is radiation oncology the only specialty that is using a PSO? " 

MORE INFORMATION 

Who do I contact if I have questions about the RO-ILS? 


AUTHORITY 

What is the Patient Safety and Quality Improvement Act of 2005 (PSQIA)?
The PSQIA is a federal law that allows providers to examine and to learn from patient safety events or incidents without fear of liability. The law authorizes patient safety organizations (PSOs), where licensed health care providers can report safety events in a confidential and privileged environment. Providers are required to sign a contract with a federally qualified PSO prior to reporting information in order to obtain the legal protections outlined in the PSQIA.

Who oversees the activities of federally qualified patient safety organizations (PSOs)?
The Agency for Healthcare Research and Quality (AHRQ), a division of the U. S. Department of Health and Human Services, oversees the activities and compliance of federally qualified PSOs. Approved PSOs, such as Clarity PSO, are listed on the AHRQ website. The HHS Office of Civil Rights (OCR) oversees the confidentiality compliance of federally qualified PSOs.

As a provider, how do I participate in RO-ILS? 
Radiation oncology practices must sign a contract with Clarity PSO to participate in RO-ILS. For additional information on the process for participation, please download the Participation Guide from the ASTRO website.

Do I still have to report to federal and state agencies, if I am reporting to Clarity PSO?
Any licensed health care provider who contracts with Clarity PSO and reports events into RO-ILS must still comply with any state or federal reporting requirements.

RO-ILS STAKEHOLDERS 

Who sponsors RO-ILS?
ASTRO serves as the gateway for providers interested in RO-ILS participation. The American Association of Physicists in Medicine (AAPM) also committed financial and intellectual support to ASTRO for this project. ASTRO contracted with Clarity PSO to develop the incident learning system and provide PSO services to interested radiation oncology practices. Clarity PSO is a division of Clarity Group, Inc., a healthcare professional liability risk management organization. Neither Clarity PSO nor Clarity Group Inc. are affiliated with ASTRO; they are independent entities providing PSO services to ASTRO members and other radiation oncology professionals.

Who served on the steering committee that developed RO-ILS?
Three physicians and four physicists served on the ASTRO-AAPM joint steering committee to oversee the development of the data elements and educational material for RO-ILS.

What is the Radiation Oncology Healthcare Advisory Council (RO-HAC)? How does it work?
RO-HAC is a group of radiation oncology professionals who provide subject matter expertise, including helping Clarity PSO to analyze, interpret and report on the data submitted into RO-ILS. RO-HAC members include radiation oncologists, physicists, dosimetrists and other patient safety experts. Members of RO-HAC are compensated for their time and must sign a contract with Clarity PSO before they may have access to the data. The leadership of ASTRO’s Clinical Affairs and Quality Council and AAPM’s Working Group for Radiation Oncology Incident Learning System (WROILS) determines and appoints members to RO-HAC, which operates as part of Clarity PSO’s patient safety evaluation system and is not subject to either ASTRO or AAPM’s review or oversight.

How can I apply to become a member of RO-HAC?
ASTRO and AAPM will issue a “call for volunteers” when new members are needed. Interested providers will need to submit an application and complete ASTRO’s Conflict of Interest Disclosure Form.

CONTRACTING 

Who can participate in the RO-ILS program?
All providers who are part of the radiation oncology treatment team, including radiation oncologists, medical physicists, dosimetrists, nurses, technologists and practice administrators, are eligible to enter data into RO-ILS if their practice has signed a contract with Clarity PSO to participate.

How do I sign up?
Interested providers may download the Participation Guide from the ASTRO website. The Participation Guide outlines step-by-step instructions for participation.

What is the Participation Guide?
The Participation Guide is a document outlining the steps for RO-ILS participation. A list of the data elements collected in RO-ILS, a sample contract and additional educational material pertinent to RO-ILS are also contained in the Participation Guide. Download the Participation Guide.

If my institution already reports to another PSO, can we still participate in RO-ILS?
Yes. An institution can participate in more than one PSO.

Are there different requirements for contracting with Clarity PSO depending on practice setting?
No. Clarity PSO’s requirements for contracting are the same regardless of practice setting.

Who signs the contract with Clarity PSO?
The entity that signs the contract with Clarity PSO will depend on your institution. Clarity PSO will work with you to determine the plan that best meets the needs of your department and institution.

  • A hospital can sign a contract on behalf of the radiation oncology department. This scenario allows all members of the department to be covered under the contract, as the entire department is part of a legal entity (i.e., the hospital). The contract would state that everyone who works within the department is participating in RO-ILS, and is therefore covered by the terms of the contract. No specific practitioner names are included on the contract in this scenario.
  • A group practice that works within or contracts with a hospital can sign a contract with Clarity PSO. If the physicians or physicists are part of a group practice and contract with a hospital, the group is still considered a legally separate entity.

How much does it cost to participate?
Currently, there is no cost to participate.

Who do I contact for additional guidance during the contracting process?
The contracting process will be different for each institution. Please contact Clarity PSO (radoncsupport@claritygrp.com) if your institution has specific questions about the contract. Please contact ASTRO (ASTRO) if you need guidance on how to begin discussions and/or gain support within your institution for RO-ILS participation. It is also recommended that you consult qualified legal counsel.

DATA COLLECTION  

How were the data elements developed? 
Using the Consensus recommendations for incident learning database structures in radiation oncology (E.C. Ford, L. Fong de los Santos, T. Pawlicki, S. Sutlief, P. Dunscombe, Med Phys, 39(12), 7272-7290, 2012) as a baseline, Clarity PSO and the ASTRO-AAPM joint steering committee identified a template for the collection of commonly reported radiation oncology incidents. Clarity PSO built RO-ILS using this template. A list of the data elements is available in the Participation Guide.

Can we map our current incident learning system to RO-ILS? 
Currently, we do not have a mechanism to map RO-ILS with already existing incident learning systems.

Who is able to enter data and perform analysis? 
Each contract receives three user names and passwords. One user name and password serves as a general login and grants access to the “Submit Event” page, where the user performs initial, front-line reporting. The additional two logins serve as full-access logins and grant access to the “My Review” page, as well as the “Submit Event” page. The “My Review” page is where users enter follow-up analysis and eventually report the data to the PSO. It is up to the individual institution to decide who is responsible for submitting incidents and who is responsible for completing the follow-up analysis. The institution should share logins among users, as needed.

Do I have to disclose protected health information (PHI), as defined in the Health Insurance Portability and Accountability Act (HIPAA), when entering data into the RO-ILS portal? 
The only patient information providers report into RO-ILS are patient’s age (as a range) and gender, which are required by AHRQ.

How do I know when to submit a report to the PSO? 
RO-ILS does not place specifications or limits on the type of data reported to Clarity PSO. We encourage participating institutions to submit any incidents that may be interpreted in a meaningful way to potentially improve quality and safety in radiation therapy. This could include, for example, information about near-misses or patient safety incidents.

How will I know the PSO received my information after I submit a report?  
You can run a report from the RO-ILS portal to view your reports transmitted to Clarity PSO.

If I submit an event to the PSO and then add additional information, do I have to resubmit the event? 
No. When data are extracted from the system, it will automatically default to the most current information, and the additional information entered will be reported.

Can I query the database? 
You have the ability to query your own data within RO-ILS. Should you want to do further research or analysis using additional data from the national database, you will need to submit a request to Clarity PSO to access non-identifiable, aggregate data.

DATA SECURITY 

How is RO-ILS set up? 
RO-ILS is a Web-based portal hosted within Clarity’s network. From an implementation standpoint, the portal is either used over an SSL connection (Port 443) or a VPN connection (Port 80). No servers are required for the users. The hosting environment at Clarity is Microsoft Server Farm operating the .NET environment using SQL Server as the database. None of these components are installed at your location. This is a Software as a Service (SaaS) application. Clarity monitors and maintains the scalability of the database.

How do you ensure there is no unauthorized access, use or disclosure to data with RO-ILS? 
Clarity maintains proper firewalls, such as CiscoFirewall and Cisco Switch on Windows 2008 Servers. Incremental data are backed up hourly and full backups are performed each night and backed up offsite with three months of backups retained. Additionally, the data center is physically secured and monitored throughout the day for performance, health and security.

How do Clarity Group, Inc. and Clarity PSO remain compliant with the Health Insurance Portability and Accountability Act (HIPAA)? 
Clarity Group, Inc. and Clarity PSO engage in HIPAA compliance activities as required by HIPAA and its implementing privacy, security, breach notification and enforcement regulations and the U.S. Health and Human Services Office for Civil Rights. These activities include: 

  • Annual, and more frequently if indicated, HIPAA education and training to Clarity Group, Inc. and Clarity PSO employees 
  • Annual HIPAA education to subcontractors 
  • Signed business associate agreements with clients, business associates and subcontractors 
  • Internal processes and committees to facilitate HIPAA compliance (e.g. risk assessments, policies) 

What is the best browser to use when submitting data to RO-ILS? 
The RO-ILS portal is best viewed in Internet Explorer 8, Internet Explorer 9, and Internet Explorer 10. Clarity PSO is in the process of testing the compatibility and functionality of other browsers.

Can users view the RO-ILS portal over mobile or tablet devices? 
Yes. Users can view the RO-ILS portal over mobile or tablet devices running Windows, iOS and Android operating systems via a browser. There are no applications installed on mobile devices. Optimal viewing and performance is in Internet Explorer.

Who can access the data once I submit it to RO-ILS? 
Only providers covered under your contract are allowed to see the data you entered into RO-ILS. Providers from other institutions will not see your data and vice versa. Only Clarity PSO staff has access to identifiable data after submission to Clarity PSO.  
All data shared with contracted consultants (e.g., RO-HAC) are stripped of identifying elements and aggregated, as required by the PSQIA and HIPAA; however, there may be instances where RO-HAC may request or be required to view identifiable data in order to advance a particular clinical or patient safety activity. Clarity PSO and the individual RO-HAC members sign agreements that comply with PSQIA and HIPAA, to protect the confidentiality of identifiable data that are shared.

Will my information be known to and shared with anyone outside of RO-ILS? 
No. Information shared with other providers participating in RO-ILS and/or ASTRO and AAPM is “nonidentified,” as that term is defined in the PSQIA, meaning that it is stripped of identifying elements, including information relating to health care providers.
A provider can disclose his or her information, under certain circumstances, in an identified manner by signing an Authorized Disclosure Form. This permits an outside party to view the identifiable information. For example, a provider may want additional support, expert recommendations or further analysis on a serious event. Clarity PSO will provide an Authorized Disclosure Form upon request.

What if I begin reporting data to RO-ILS and then choose to stop? Are the data returned to me? 
All data are returned to the original owner and deleted from Clarity’s servers; however, it is not possible to retract information submitted to Clarity PSO once included in aggregate form. The total aggregate compendium of unidentifiable data remains housed in Clarity PSO’s database.

What additional measures does Clarity take to ensure data security? 
Clarity regularly monitors and reports on invalid login attempts, valid users logging into system, dormant user account activity and user access activity. Clarity also utilizes a lockout feature to secure the electronic session after 20 minutes of inactivity within the portal. In addition, Clarity has a HIPAA security team that meets monthly to review policies and procedures relating to any incidents with the portal. 

RO-ILS BENEFITS 

Why should I participate in the RO-ILS?
RO-ILS is the only medical specialty society-sponsored incident learning system for radiation oncology. By contracting with Clarity PSO, the providers and all the data entered in the RO-ILS are protected as outlined in the PSQIA. RO-ILS ensures that information is synthesized to provide excellent education for practitioners. Other benefits include:

  • Track and analyze internal incidents while contributing to the national database.
  • Receive institution-specific summary report, including aggregate data on events entered throughout the country.
  • Receive newsletters and other publications designed to educate the radiation oncology community on how to prevent errors.

Can participation in the RO-ILS be used for Maintenance of Certification? 
Yes. RO-ILS is qualified for physicians and physicists by the American Board of Radiology (ABR) in meeting the criteria for practice quality improvement (PQI), toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program. Access the RO-ILS PQI template.

What types of reports and educational material will we receive?  
RO-ILS participants receive institution-specific summary reports (e.g., data relating to treatment technique, type of equipment, dosemetric severity scale, etc.) for their institution, including aggregate data on events entered throughout the country, developed by Clarity PSO and RO-HAC. In addition, newsletters will be produced to educate the radiation oncology community on how to prevent medical errors and on lessons learned from RO-ILS.

Is radiation oncology the only specialty that is using a PSO? 
No. Currently, there are more than 75 PSOs qualified with AHRQ, including many that work with national organizations and other specialty societies.  

MORE INFORMATION  

Who do I contact if I have questions about the RO-ILS?
Email ROILS@astro.org for general questions about RO-ILS. Contact the Clarity Help Desk at radoncsupport@claritygrp.com or 708-667-7730 for contracting or eligible professional participation concerns. 

Access the Participation Guide.

 

AHRQ: Agency for Healthcare Research and Quality. Federal agency within the U.S. Department of Health and Human Services. Responsible for the creation and oversight of the Patient Safety and Quality Improvement Act regulations. 

ASTRO-AAPM steering committee: A committee comprised of three physicians and four physicists that oversaw the development of the data elements and educational material for RO-ILS. 

Authorized Representative: Designated person with authority to sign the PSO Provider Services Agreement with Clarity PSO on behalf of the institution. The Authorized Representative is chosen based upon the institution’s processes for contract signing.  

Clarity PSO: One of the earliest PSOs qualified by AHRQ. Provides a safe learning environment for contracted providers to closely examine and learn from patient safety data. Clarity PSO is a division of Clarity Group, Inc., a health care professional liability risk management organization. Clarity Group, Inc. provides the Healthcare SafetyZone Portal to support data reporting and analysis for Clarity PSO-contracted providers. Neither Clarity PSO nor Clarity Group, Inc. is affiliated with ASTRO; they are independent entities providing PSO services to ASTRO members and other radiation oncology professionals.  

Participation Form: Form required to begin the contracting process. The form asks for basic demographic information, including institution name and address, identification of Authorized Representative and PSO Liaison. The Participation Form is found in the Participation Guide.  

Participation Guide: Document outlining the steps for RO-ILS participation. A list of the data elements collected in RO-ILS, a sample contract and additional educational material pertinent to RO-ILS are also contained in the Participation Guide. You can download the Participation Guide from the ASTRO website.  

PSQIA: Patient Safety and Quality Improvement Act of 2005. Federal act that established a voluntary reporting system to support the collection of health care quality data regarding medical incidents on a national scale. Provides federal confidentiality and privilege protections to encourage reporting and analysis of these data. With limited exceptions, information or data submitted to RO-ILS, or any other federally qualified PSO, is privileged and cannot be used against a provider in court or in disciplinary proceedings.  

PSES: Patient safety evaluation system. Mechanism for collecting, managing and analyzing information and data for reporting to or by a PSO.  

PSO: Patient safety organization. An entity authorized by Congress in the PSQIA, whose primary activity is to improve patient safety and the quality of health care delivery. Must meet the requirements stipulated in the PSQIA and must reapply for federal certification every three years.  

PSO Liaison: Designated person responsible for the institution’s participation in RO-ILS and primary point of contact for Clarity PSO.

PSWP: Patient safety work product. Any data, deliberations or analyses collected by a provider for the purposes of 1) improving quality and safety, and 2) for reporting to a PSO. All data entered into the RO-ILS portal by a participating provider are deemed to be patient safety work product. PSWP does not include data (e.g., medical records) maintained for a purpose other than improving quality and safety and/or reporting to a PSO.   

RO-HAC: Radiation Oncology Healthcare Advisory Council. A group of radiation oncology professionals who provide subject-matter expertise, including helping Clarity PSO to analyze, interpret and report on the data submitted into RO-ILS.  

RO-ILS: Radiation Oncology Incident Learning System. Web-based portal designed to collect patient safety data in radiation oncology. RO-ILS was built using the architecture and platform of Clarity Group, Inc.’s Healthcare SafetyZone Portal. 

Access the Participation Guide.

Arnold A, Delaney GP, Cassapi L, Barton M. The use of categorized time-trend reporting of radiation oncology incidents: a proactive analytical approach to improving quality and safety over time. Int J RadiatOncol Biol Phys. 2010 Dec 1;78(5):1548-54.

BissonnetteJP, Medlam G. Trend analysis of radiation therapy incidents over seven years. RadiotherOncol. 2010 Jul;96(1):139-44.

Church JA, Adams RD, HendroxLH, et al. National study to determine the comfort levels of radiation therapists and medical dosimetrists to report errors. Practical Rad Onc. 2012 Dec; 3(4): 165-70.

Clark BG, Brown RJ, Ploguin J, Dunscombe P. Patient safety improvement in radiation treatment through 5 years of incident learning. Practical Rad Onc. 2013 Jul; 3(3):157-63.

Clark BG, Brown RJ, PloquinJL, Kind AL, Grimard L. The management of radiation treatment error through incident learning. RadiotherOncol. 2010 Jun;95(3):344-9.

Evans SB, Decker R. Disclosing medical errors: a practical guide and discussion of radiation oncology-specific controversies. Int J RadiatOncol Biol Phys. 2011 Aug 1;80(5):1285-8.

Ford EC, Fong de Los Santos L, Pawlicki T, Sutlief S, Dunscombe P. Consensus recommendations for incident learning database structures in radiation oncology. Med Phys. 2012 Dec;39(12):7272-90.

Ford EC, Smith K, Harris K, Terezakis S. Prevention of a wrong-location misadministration through the use of an intradepartmental incident learning system. Med Phys. 2012 Nov;39(11):6968-71.

Huang G, Medlam G, Lee J, et al. Error in the delivery of radiation therapy: results of a quality assurance review. Int J RadiatOncol Biol Phys. 2005 Apr 1;61(5):1590-5. PubMedPMID: 15817367.

Jaffray DA, Langen KM, Mageras G, et al. Assuring safety and quality in image guided delivery of radiation therapy. Practical Rad Onc. 2013 Jan; 3: 167-70.

KalapurakalJA, Zafirovski A, Smith J, et al. A comprehensive quality assurance program for personnel and procedures in radiation oncology: value of voluntary error reporting and checklists. Int J RadiatOncol Biol Phys. 2013 Jun 1;86(2):241-8.

MargalitDN, ChenYH, Catalano PJ, et al. Technological advancements and error rates in radiation therapy delivery. Int J RadiatOncol Biol Phys. 2011 Nov 15;81(4):e673-9.

MoranJM, Dempsey M, Eisbruch A, et al. Safety considerations for IMRT: executive summary. Med Phys. 2011 Sep;38(9):5067-72.

Mutic S, BrameRS, Oddiraju S, et al. Event (error and near-miss) reporting and learning system for process improvement in radiation oncology. Med Phys. 2010 Sep;37(9):5027-36.

OdleTG, Rosier N. Radiation therapy safety: The critical role of the radiation therapist. Albuquerque, NM: American Society of Radiologic Technologists Education and Research Foundation; 2012.
Santanam L, BrameRS, Lindsey A, et al. Eliminating inconsistencies in simulation and treatment planning orders in radiation therapy. Int J RadiatOncol Biol Phys. 2013 Feb 1;85(2):484-91. 

Terezakis SA, Harris KM, Ford E, et al. An evaluation of departmental radiation oncology incident reports: Anticipating a national reporting system. Practical Rad Onc. 2013 Mar; 85(4): 919-23. 

Terezakis SA, Pronovost P, Harris K, Deweese T, Ford E. Safety strategies in an academic radiation oncology department and recommendations for action. Jt Comm J Qual Patient Saf. 2011 Jul;37(7):291-9.  

YeungTK, Bortolotto K, Cosby S, Hoar M, Lederer E. Quality assurance in radiotherapy: evaluation of errors and incidents recorded over a 10 year period. RadiotherOncol. 2005 Mar; 74(3):283-91. 

Zietman A, Palta J, Steinberg M, et al. Safety is no accident: a framework for quality radiation oncology and care. Fairfax, VA: American Society for Radiation Oncology; 2012. 

To recommend a publication for listing on this page, email RO-ILS.

Content last updated 6/29/2015
About ASTRO | Contact Us | Sitemap | Advertising | Terms of Use | Privacy Policy | My ASTRO | COI Policies | Career Center
News & Media Center | Educational Resources | Meetings and Events | Clinical Practice | Research | Practice Management | Advocacy | Membership
8280 Willow Oaks Corporate Drive, Suite 500, Fairfax, VA 22031 | Phone:703-502-1550 | Toll Free:1-800-962-7876 | Fax:703-502-7852
Copyright © 2015 American Society for Radiation Oncology